Loading…

Tongluo Jiedu as an adjuvant therapy for oral cancer

Oral cancer is one of the malignant neoplasms that present major global health challenge. It is the sixth most prevalent type of cancer in the world, with a high incidence and mortality rate. This letter is a review of the study by Yin et al which was published in the World Journal of Clinical Cases...

Full description

Saved in:
Bibliographic Details
Published in:World journal of clinical cases 2025-02, Vol.13 (5)
Main Authors: Lomelí Martínez, Sarah Monserrat, Martínez Nieto, Melissa, Mercado González, Ana Esther
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-crossref_primary_10_12998_wjcc_v13_i5_979093
container_end_page
container_issue 5
container_start_page
container_title World journal of clinical cases
container_volume 13
creator Lomelí Martínez, Sarah Monserrat
Martínez Nieto, Melissa
Mercado González, Ana Esther
description Oral cancer is one of the malignant neoplasms that present major global health challenge. It is the sixth most prevalent type of cancer in the world, with a high incidence and mortality rate. This letter is a review of the study by Yin et al which was published in the World Journal of Clinical Cases (2024). The study evaluated the effect of Tongluo Jiedu as an adjuvant treatment for oral cancer. Over the years, there has been a continuous search for effective and less invasive treatments for oral cancer. This article emphasizes and discusses various therapeutic options currently available, and it highlights that early intervention and multidisciplinary management are crucial for improving outcomes. Traditional Chinese Medicine, particularly Tongluo Jiedu, presents potential complementary approach to conventional oral cancer therapies. Future research on Tongluo Jiedu should be focused on validation of its efficacy and safety through large, well-designed clinical trials, as well as better understanding of the molecular mechanisms involved, and optimization of therapeutic combinations. Additionally, continuous education of health professionals is key to the effective and safe integration of this traditional medicine into clinical practice. Continuous research is essential for optimization of therapeutic strategies and for addressing the challenges presented by this neoplasm.
doi_str_mv 10.12998/wjcc.v13.i5.97909
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_12998_wjcc_v13_i5_97909</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_12998_wjcc_v13_i5_97909</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_12998_wjcc_v13_i5_979093</originalsourceid><addsrcrecordid>eNqdzr0OgjAYheHGaCJRbsCpNwB-pfLT2WiMM3vzpRSFICUtYLh7lTg4O513OclDyI5ByCIhsv2zViocGQ-rOBSpALEgXsQhDTKRwPKn18R3rgYAxiBmCffIITftrRkMvVa6GCg6ii3Foh5GbHva37XFbqKlsdRYbKjCVmm7JasSG6f9725IdD7lx0ugrHHO6lJ2tnqgnSQDORPlhyjfRFnFcibyv04vhexGsA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Tongluo Jiedu as an adjuvant therapy for oral cancer</title><source>PMC (PubMed Central)</source><creator>Lomelí Martínez, Sarah Monserrat ; Martínez Nieto, Melissa ; Mercado González, Ana Esther</creator><creatorcontrib>Lomelí Martínez, Sarah Monserrat ; Martínez Nieto, Melissa ; Mercado González, Ana Esther</creatorcontrib><description>Oral cancer is one of the malignant neoplasms that present major global health challenge. It is the sixth most prevalent type of cancer in the world, with a high incidence and mortality rate. This letter is a review of the study by Yin et al which was published in the World Journal of Clinical Cases (2024). The study evaluated the effect of Tongluo Jiedu as an adjuvant treatment for oral cancer. Over the years, there has been a continuous search for effective and less invasive treatments for oral cancer. This article emphasizes and discusses various therapeutic options currently available, and it highlights that early intervention and multidisciplinary management are crucial for improving outcomes. Traditional Chinese Medicine, particularly Tongluo Jiedu, presents potential complementary approach to conventional oral cancer therapies. Future research on Tongluo Jiedu should be focused on validation of its efficacy and safety through large, well-designed clinical trials, as well as better understanding of the molecular mechanisms involved, and optimization of therapeutic combinations. Additionally, continuous education of health professionals is key to the effective and safe integration of this traditional medicine into clinical practice. Continuous research is essential for optimization of therapeutic strategies and for addressing the challenges presented by this neoplasm.</description><identifier>ISSN: 2307-8960</identifier><identifier>EISSN: 2307-8960</identifier><identifier>DOI: 10.12998/wjcc.v13.i5.97909</identifier><language>eng</language><ispartof>World journal of clinical cases, 2025-02, Vol.13 (5)</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-crossref_primary_10_12998_wjcc_v13_i5_979093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Lomelí Martínez, Sarah Monserrat</creatorcontrib><creatorcontrib>Martínez Nieto, Melissa</creatorcontrib><creatorcontrib>Mercado González, Ana Esther</creatorcontrib><title>Tongluo Jiedu as an adjuvant therapy for oral cancer</title><title>World journal of clinical cases</title><description>Oral cancer is one of the malignant neoplasms that present major global health challenge. It is the sixth most prevalent type of cancer in the world, with a high incidence and mortality rate. This letter is a review of the study by Yin et al which was published in the World Journal of Clinical Cases (2024). The study evaluated the effect of Tongluo Jiedu as an adjuvant treatment for oral cancer. Over the years, there has been a continuous search for effective and less invasive treatments for oral cancer. This article emphasizes and discusses various therapeutic options currently available, and it highlights that early intervention and multidisciplinary management are crucial for improving outcomes. Traditional Chinese Medicine, particularly Tongluo Jiedu, presents potential complementary approach to conventional oral cancer therapies. Future research on Tongluo Jiedu should be focused on validation of its efficacy and safety through large, well-designed clinical trials, as well as better understanding of the molecular mechanisms involved, and optimization of therapeutic combinations. Additionally, continuous education of health professionals is key to the effective and safe integration of this traditional medicine into clinical practice. Continuous research is essential for optimization of therapeutic strategies and for addressing the challenges presented by this neoplasm.</description><issn>2307-8960</issn><issn>2307-8960</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNqdzr0OgjAYheHGaCJRbsCpNwB-pfLT2WiMM3vzpRSFICUtYLh7lTg4O513OclDyI5ByCIhsv2zViocGQ-rOBSpALEgXsQhDTKRwPKn18R3rgYAxiBmCffIITftrRkMvVa6GCg6ii3Foh5GbHva37XFbqKlsdRYbKjCVmm7JasSG6f9725IdD7lx0ugrHHO6lJ2tnqgnSQDORPlhyjfRFnFcibyv04vhexGsA</recordid><startdate>20250216</startdate><enddate>20250216</enddate><creator>Lomelí Martínez, Sarah Monserrat</creator><creator>Martínez Nieto, Melissa</creator><creator>Mercado González, Ana Esther</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20250216</creationdate><title>Tongluo Jiedu as an adjuvant therapy for oral cancer</title><author>Lomelí Martínez, Sarah Monserrat ; Martínez Nieto, Melissa ; Mercado González, Ana Esther</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_12998_wjcc_v13_i5_979093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Lomelí Martínez, Sarah Monserrat</creatorcontrib><creatorcontrib>Martínez Nieto, Melissa</creatorcontrib><creatorcontrib>Mercado González, Ana Esther</creatorcontrib><collection>CrossRef</collection><jtitle>World journal of clinical cases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lomelí Martínez, Sarah Monserrat</au><au>Martínez Nieto, Melissa</au><au>Mercado González, Ana Esther</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tongluo Jiedu as an adjuvant therapy for oral cancer</atitle><jtitle>World journal of clinical cases</jtitle><date>2025-02-16</date><risdate>2025</risdate><volume>13</volume><issue>5</issue><issn>2307-8960</issn><eissn>2307-8960</eissn><abstract>Oral cancer is one of the malignant neoplasms that present major global health challenge. It is the sixth most prevalent type of cancer in the world, with a high incidence and mortality rate. This letter is a review of the study by Yin et al which was published in the World Journal of Clinical Cases (2024). The study evaluated the effect of Tongluo Jiedu as an adjuvant treatment for oral cancer. Over the years, there has been a continuous search for effective and less invasive treatments for oral cancer. This article emphasizes and discusses various therapeutic options currently available, and it highlights that early intervention and multidisciplinary management are crucial for improving outcomes. Traditional Chinese Medicine, particularly Tongluo Jiedu, presents potential complementary approach to conventional oral cancer therapies. Future research on Tongluo Jiedu should be focused on validation of its efficacy and safety through large, well-designed clinical trials, as well as better understanding of the molecular mechanisms involved, and optimization of therapeutic combinations. Additionally, continuous education of health professionals is key to the effective and safe integration of this traditional medicine into clinical practice. Continuous research is essential for optimization of therapeutic strategies and for addressing the challenges presented by this neoplasm.</abstract><doi>10.12998/wjcc.v13.i5.97909</doi></addata></record>
fulltext fulltext
identifier ISSN: 2307-8960
ispartof World journal of clinical cases, 2025-02, Vol.13 (5)
issn 2307-8960
2307-8960
language eng
recordid cdi_crossref_primary_10_12998_wjcc_v13_i5_97909
source PMC (PubMed Central)
title Tongluo Jiedu as an adjuvant therapy for oral cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T16%3A45%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tongluo%20Jiedu%20as%20an%20adjuvant%20therapy%20for%20oral%20cancer&rft.jtitle=World%20journal%20of%20clinical%20cases&rft.au=Lomel%C3%AD%20Mart%C3%ADnez,%20Sarah%20Monserrat&rft.date=2025-02-16&rft.volume=13&rft.issue=5&rft.issn=2307-8960&rft.eissn=2307-8960&rft_id=info:doi/10.12998/wjcc.v13.i5.97909&rft_dat=%3Ccrossref%3E10_12998_wjcc_v13_i5_97909%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-crossref_primary_10_12998_wjcc_v13_i5_979093%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true